215 related articles for article (PubMed ID: 36410923)
1. Past, Present, and Future Management of Localized Biliary Tract Malignancies.
Li J; Rocha FG; Mayo SC
Surg Oncol Clin N Am; 2023 Jan; 32(1):83-99. PubMed ID: 36410923
[TBL] [Abstract][Full Text] [Related]
2. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
Kawarada Y; Isaji S; Taoka H; Tabata M; Das BC; Yokoi H
J Gastrointest Surg; 1999; 3(4):369-73. PubMed ID: 10482688
[TBL] [Abstract][Full Text] [Related]
3. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment of advanced or recurrent biliary tract cancer.
Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
[TBL] [Abstract][Full Text] [Related]
5. Malignancies of the biliary tree.
Pitt HA; Dooley WC; Yeo CJ; Cameron JL
Curr Probl Surg; 1995 Jan; 32(1):1-90. PubMed ID: 7528652
[No Abstract] [Full Text] [Related]
6. Role of laparoscopy in the evaluation of biliary tract cancer.
Corvera CU; Weber SM; Jarnagin WR
Surg Oncol Clin N Am; 2002 Oct; 11(4):877-91. PubMed ID: 12607577
[TBL] [Abstract][Full Text] [Related]
7. Hilar cholangiocarcinoma.
Zaydfudim VM; Rosen CB; Nagorney DM
Surg Oncol Clin N Am; 2014 Apr; 23(2):247-63. PubMed ID: 24560109
[TBL] [Abstract][Full Text] [Related]
8. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
[TBL] [Abstract][Full Text] [Related]
9. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.
Ten Haaft BH; Pedregal M; Prato J; Klümpen HJ; Moreno V; Lamarca A
Eur J Cancer; 2024 Mar; 199():113564. PubMed ID: 38266541
[TBL] [Abstract][Full Text] [Related]
10. The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma.
Nasu Y; Tanaka E; Hirano S; Tsuchikawa T; Kato K; Matsumoto J; Shichinohe T; Kondo S
J Hepatobiliary Pancreat Sci; 2012 May; 19(3):274-80. PubMed ID: 21879321
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of cholangiocarcinoma.
Jarnagin WR; Shoup M
Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
[TBL] [Abstract][Full Text] [Related]
12. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
Wheless M; Agarwal R; Goff L; Lockney N; Padmanabhan C; Heumann T
Curr Treat Options Oncol; 2024 Jan; 25(1):127-160. PubMed ID: 38177560
[TBL] [Abstract][Full Text] [Related]
13. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
[TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
15. How I treat biliary tract cancer.
Lamarca A; Edeline J; Goyal L
ESMO Open; 2022 Feb; 7(1):100378. PubMed ID: 35032765
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
[TBL] [Abstract][Full Text] [Related]
17. The state of therapy modalities in clinic for biliary tract cancer.
Chen W; Hu Z; Song J; Wu Y; Zhang B; Zhang L
Front Biosci (Landmark Ed); 2022 Jun; 27(6):185. PubMed ID: 35748261
[TBL] [Abstract][Full Text] [Related]
18. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
19. Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.
Rhodin KE; Liu A; Bartholomew A; Kramer R; Parameswaran A; Uronis H; Strickler J; Hsu D; Morse MA; Shah KN; Herbert G; Zani S; Nussbaum DP; Allen PJ; Lidsky ME
Ann Surg Oncol; 2023 Aug; 30(8):4813-4821. PubMed ID: 37188803
[TBL] [Abstract][Full Text] [Related]
20. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
